Institute For Cancer & Blood is categorized under Medical Research in Beverly Hills, CA and active since 1959.
Institute For Cancer & Blood was established in 1959, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 8133190 by the NAICS.
If you are seeking more information, feel free to contact Susan Kane, Administrator at the company’s single location by writing to 150 North Robertson Boulevard # 316, Beverly Hills, California CA 90211 or by phoning (310) 657-4706. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Institute For Cancer & Blood |
Contact Person: | Susan Kane, Administrator |
Address: | 150 North Robertson Boulevard # 316, Beverly Hills, California 90211 |
Phone Number: | (310) 657-4706 |
Annual Revenue (USD): | Unknown |
Founded: | 1959 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 8133190 |
Share This Business: |
Institute For Cancer & Blood was started in 1959 to provide professional Medical Research under the SIC code 8733 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Susan Kane, Administrator for inquiries that concern Institute For Cancer & Blood by calling the company number (310) 657-4706, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Cancer & Blood can be found at the coordinates 34.068136,-118.383633 as well as the street address 150 North Robertson Boulevard # 316 in Beverly Hills, California 90211.
For its online presence, you may visit Institute For Cancer & Blood’s website at and engage with its social media outlets through on Twitter and on Facebook.